Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs

BACKGROUND: Nonresectable mast cell tumors (MCT) in dogs remain a therapeutic challenge, and investigation of novel combination therapies is warranted. Intermittent administration of tyrosine kinase inhibitors (TKI) combined with cytotoxic chemotherapy may effectively chemosensitize canine MCT while...

Descripción completa

Detalles Bibliográficos
Autores principales: Burton, J.H., Venable, R.O., Vail, D.M., Williams, L.E., Clifford, C.A., Axiak‐Bechtel, S.M., Avery, A.C., Thamm, D.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895362/
https://www.ncbi.nlm.nih.gov/pubmed/26119008
http://dx.doi.org/10.1111/jvim.13573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895362/
https://www.ncbi.nlm.nih.gov/pubmed/26119008
http://dx.doi.org/10.1111/jvim.13573

Ejemplares similares